ArticleNature medicine2019
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.
Dong Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
114 papers cite itlatest 60 shown
this papertrialcites it